content Introduction Methods Results 1- Introduction to drug safety 2- The Drug Studies on Safety. 1- Pre-Approval studies 2- Post-Approval studies 3- Post marketing Studies Discussion References Introduction Pharmaceutical companies today like to produce many new drugs‚ but there are several potential risks associate with the production of any new medicine. In addition‚ there is numerous new side effects come from approved drugs. This paper aims to help understand
Premium Pharmacology Pharmaceutical industry Clinical research
Glaxosmithkline is a global leader in the market of pharmaceutical goods and services‚ currently holding 7% of market share in this field. Formerly Glaxo Wellcome plc‚ the firm merged in December 2000 with Smithkline Beecham‚ a leading manufacturer of medical and consumer healthcare goods. ‚ however there is much dispute over the motives behind the merger and what Glaxo Wellcome sought to gain through the collaboration. This is of particular concern as following the merger‚ many shareholders and
Premium Pharmaceutical industry
I have been blessed with living with ADHD for the entirety of my life. For the majority of my life‚ I relied heavily on treating ADHD with various different pharmaceuticals. In school‚ I was regularly being ridiculed and shamed for my impulsive behaviors‚ which wasn’t the most comforting experience. I can also remember being an intensely creative and outspoken little runt‚ who enjoyed reading books about science and human biology. I came to rely heavily on these medicines as I entered into college
Premium College 2008 albums Graduate school
Big‚ Bad Pharma: An Unnecessary Evil Big‚ Bad Pharma: An Unnecessary Evil Big Pharma‚ or the pharmaceutical industry’s giant corporations‚ have earned record profits‚ falsified clinical trial data and corrupted the healthcare industry according to many industry critics including a recent report posted on Globalresearch.ca.[1] The industry’s story parallels the history of other corporate monopolies such as Big Oil‚ the Railroad Industry‚ Big Agriculture‚ banking interests and other industrial giants
Premium Pharmacology Clinical trial Medicine
currently has two reportable segments‚ the Pharmaceutical Segment and the Vaccines and Infectious Diseases Segment. Merck sells products through several channels including wholesalers‚ retailers‚ hospitals‚ clinics‚ government and managed health services providers. In the 1980’s the Merck was very successful in producing 10 major new drugs and had a very healthy pipeline. In later years‚ Merck has entered into joint ventures with many other pharmaceutical companies in order to expand its pipeline
Premium Generic drug Pharmaceutical industry Mergers and acquisitions
atent-protection-ready/ Datamonitor Hoover ’s Company Records. Merck and Co.‚Inc. (2012). Retrieved from http://www.hoovers.com/company/Merck__Co_Inc/rrytji-1-1njhw5.html Hoover ’s Company Records CNN.com. (2011). Fortune 500 2011: Industry: Pharmaceuticals. Retrieved from http://money.cnn.com/magazines/fortune/fortune500/2011/industries/21/index.html Merck.com NYSE (2012). Retrieved from: http://www.advfn.com/p.php?pid=financials&symbol=NYSE%3AMRK Pfizer.com US Department of Treasury. (2012). Retrieved
Premium Pharmaceutical industry Pharmacology Generic drug
For me as a former worker in the medical field‚ who is coming from the other part of the world‚ the predilection for medicament over usage in the U.S. was always surprising. Therefore‚ I was expecting to see in this video issues about psycho-neurological side effects of overmedicated in somatically ill child. There were several memorable moments which impacted my mind. One of them was Jacob’s story. It was sad to see how the persistent labeling with hyperactivity by preschool teachers took
Premium Bipolar disorder Schizophrenia Antipsychotic
A project report on INTER COMPANY ANALYSIS Analysis of Pharmaceutical Industry in the Indian environment and comparative analysis among Ranbaxy Laboratories Ltd. and Cipla Ltd. Under the guidance of Prof P. Madhavan Visiting Professor‚ IIM Rohtak Undertaken by Ashwani Kumar Atif Aslam Dhiraj Rishiraj Sisodiya Shashi Singh pgp03.016 pgp03.017 pgp03.019 pgp03.054 pgp03.053 This project report is submitted as a partial requirement for the fulfilment of the Business Analysis and Valuation
Premium Financial ratios Financial ratio Generic drug
ELI LILLY IN INDIA RETHINKING THE JOINT VENTURE Kishore – 01 STRATEGY Abhay Abhishek Kunal – 05 Anil Kumar Jadli – 11 J.Harish – 25 Khushal Malik – 28 Sharad Singh – 49 PHARMACEUTICAL INDUSTRY – Global Trend • • • • Mainly concentrated in the United States‚ Europe‚ and Japan Developing a drug from discovery to launch took 10 to 12 years. Cost of development of drug is between $500-$800 million. Drugs were strictly controlled by government agencies: o Food and Drug Administration (FDA) – USA‚
Premium Generic drug Pharmaceutical industry Ranbaxy Laboratories
…………………………………………………………………………….17 EFAS Matrix Analysis ……………………………………………………………………….. 18 Introduction Global pharmaceuticals grew by 3.6% in 2010 to reach over $733 billion with projections reaching $981 billion by the year 2015 (Pharmaceuticals Industry Profile: Global‚ 2011). Pfizer‚ the world leader in the global pharmaceuticals market‚ controls an impressive 9.4% of the global market share (Pharmaceuticals Industry Profile: Global‚ 2011). Sometimes described as Frankenstein’s Monster‚ Pfizer has been aggressively
Premium Corporate governance Board of directors Pharmaceutical industry